Invention Application
- Patent Title: Combination Therapies Comprising Daratumumab, Bortezomib, Thalidomide and Dexamethasone and Their Uses
-
Application No.: US17691050Application Date: 2022-03-09
-
Publication No.: US20220204638A1Publication Date: 2022-06-30
- Inventor: Xiangyang Liu , Jordan Schecter
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C12N5/0775 ; A61P35/00
Abstract:
Disclosed herein are combination therapies comprising daratumumab and their uses.
Public/Granted literature
- US2584314A Pyrazolopyridines Public/Granted day:1952-02-05
Information query
